Enhancing Repetitive Transcranial Magnetic Stimulation Effects for Depression Treatment: Navigare Necesse Est—and Smart Clinical Trial Designs

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Klooster D.C.W.
        • Ferguson M.A.
        • Boon P.A.J.M.
        • Baeken C.
        Personalizing repetitive transcranial magnetic stimulation parameters for depression treatment using multimodal neuroimaging.
        Biol Psychiatry Cogn Neurosci Neuroimaging. 2022; 7: 536-545
        • Brunoni A.R.
        • Chaimani A.
        • Moffa A.H.
        • Razza L.B.
        • Gattaz W.F.
        • Daskalakis Z.J.
        • Carvalho A.F.
        Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: A systematic review with network meta-analysis.
        JAMA Psychiatry. 2017; 74: 143-152
        • Cole E.J.
        • Phillips A.L.
        • Bentzley B.S.
        • Stimpson K.H.
        • Nejad R.
        • Barmak F.
        • et al.
        Stanford Neuromodulation Therapy (SNT): A double-blind randomized controlled trial.
        Am J Psychiatry. 2022; 179: 132-141
        • Padberg F.
        • Bulubas L.
        • Mizutani-Tiebel Y.
        • Burkhardt G.
        • Kranz G.S.
        • Koutsouleris N.
        • et al.
        The intervention, the patient and the illness – Personalizing non-invasive brain stimulation in psychiatry.
        Exp Neurol. 2021; 341: 113713
        • Dinur-Klein L.
        • Dannon P.
        • Hadar A.
        • Rosenberg O.
        • Roth Y.
        • Kotler M.
        • Zangen A.
        Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: A prospective, randomized controlled trial.
        Biol Psychiatry. 2014; 76: 742-749
        • Fridriksson J.
        • Rorden C.
        • Elm J.
        • Sen S.
        • George M.S.
        • Bonilha L.
        Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: A randomized clinical trial.
        JAMA Neurol. 2018; 75: 1470-1476
        • Goerigk S.A.
        • Padberg F.
        • Chekroud A.
        • Kambeitz J.
        • Bühner M.
        • Brunoni A.R.
        Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS.
        Brain Stimul. 2021; 14: 906-912
        • Stallard N.
        An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information.
        Trials. 2011; 12: A2
        • COVID-19 Mental Disorders Collaborators
        Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
        Lancet. 2021; 398: 1700-1712

      Linked Article

      • Personalizing Repetitive Transcranial Magnetic Stimulation Parameters for Depression Treatment Using Multimodal Neuroimaging
        Biological Psychiatry: Cognitive Neuroscience and NeuroimagingVol. 7Issue 6
        • Preview
          Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment for neuropsychiatric disorders such as major depressive disorder, although the clinical efficacy is still rather modest. Overly general stimulation protocols that consider neither patient-specific depression symptomology nor individualized brain characteristics, such as anatomy or structural and functional connections, may be the cause of the high inter- and intraindividual variability in rTMS clinical responses.
        • Full-Text
        • PDF
        Open Access